Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-046902
Filing Date
2024-11-19
Accepted
2024-11-19 18:45:00
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3098
  Complete submission text file 0001493152-24-046902.txt   4501
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
Invizyne Technologies Inc (Issuer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 10386 WATERIDGE CIRCLE # 353 SAN DIEGO CA 92121
Business Address
Heltzen Michael (Reporting) CIK: 0002030840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42204 | Film No.: 241477764